Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.07.2018 | Case report

Reslizumab

Disseminated aspergillosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wood C, et al. Disseminated aspergillosis after IL-5 therapy for severe asthma. American Journal of Respiratory and Critical Care Medicine 197: no pagination abstr. A1262, Jan 2018 [abstract] - USA Wood C, et al. Disseminated aspergillosis after IL-5 therapy for severe asthma. American Journal of Respiratory and Critical Care Medicine 197: no pagination abstr. A1262, Jan 2018 [abstract] - USA
Metadaten
Titel
Reslizumab
Disseminated aspergillosis: case report
Publikationsdatum
01.07.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-49765-8

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Omalizumab

Case report

Doxorubicin

Case report

Dexamethasone

Case report

Interferon-β

Case report

Pazufloxacin